CAROLINA MEHAFFY • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
ALFONSO MENDOZA • Gobal Health Phama Research Unit, Tres Cantos Medicines
Development Campus (TCMDC), GlaxoSmithKline, Madrid, Spain
MANON MOTTET • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
KENAN C. MURPHY • Microbiology and Physiological Systems, University of Massachusetts
Medical School, Worcester, MA, USA
CARL NATHAN • Department of Microbiology and Immunology, Weill Cornell Medicine, New
York, NY, USA
JERRY A. NICK • Department of Medicine, National Jewish Health, Denver, CO, USA
JE ´ RO ˆ ME NIGOU • Tuberculosis & Infection Biology Department, Institut de Pharmacologie et
de Biologie Structurale (IPBS), Centre National de la Recherche Scientifique (CNRS),
Toulouse, France; Universite ´ de Toulouse, Universite ´ Paul Sabatier (Toulouse III), Toulouse,
France
JAHN NITSCHKE • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
ANIL K. OJHA • Division of Genetics, Wadsworth Center, New York State Department of
Health, Albany, NY, USA; Department of Biomedical Sciences, University at Albany,
Albany, NY, USA
ANDREW J. OLIVE • Department of Microbiology and Molecular Genetics, Michigan State
University, East Lansing, MI, USA
TANYA PARISH • Center for Global Infectious Disease Research, Seattle Children’s Research
Institute, Seattle, WA, USA
MARI ´ A PEN ˜ A • United States Department of Health and Human Services, Health Resources
and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease
Program, Baton Rouge, LA, USA
ESTHER PE ´ REZ-HERRA ´ N • Gobal Health Phama Research Unit, Tres Cantos Medicines
Development Campus (TCMDC), GlaxoSmithKline, Madrid, Spain
KYLE A. PLANCK • Division of Infectious Diseases, Department of Medicine, Weill Cornell
Medicine, New York, NY, USA; Department of Pharmacology, Weill Cornell Medicine,
New York, NY, USA
KYU RHEE • Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine,
New York, NY, USA; Department of Microbiology and Immunology, Weill Cornell
Medicine, New York, NY, USA
MARCO A. RIOJAS • ATCC, BEI Resources, Manassas, VA, USA
JEREMY M. ROCK • Laboratory of Host-Pathogen Biology, The Rockefeller University, New
York, NY, USA
LILIANA RODRIGUES • Global Health and Tropical Medicine, GHTM, Instituto de Higiene
e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisbon, Portugal
JOAN M. RYAN • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
MAX SALFINGER • College of Public Health & Morsani College of Medicine, University of
South Florida, Tampa, FL, USA
SCARLET S. SHELL • Department of Biology & Biotechnology, Worcester Polytechnic Institute,
Worcester, MA, USA; Program in Bioinformatics & Computational Biology, Worcester
Polytechnic Institute, Worcester, MA, USA
xiv
Contributors
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
ALFONSO MENDOZA • Gobal Health Phama Research Unit, Tres Cantos Medicines
Development Campus (TCMDC), GlaxoSmithKline, Madrid, Spain
MANON MOTTET • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
KENAN C. MURPHY • Microbiology and Physiological Systems, University of Massachusetts
Medical School, Worcester, MA, USA
CARL NATHAN • Department of Microbiology and Immunology, Weill Cornell Medicine, New
York, NY, USA
JERRY A. NICK • Department of Medicine, National Jewish Health, Denver, CO, USA
JE ´ RO ˆ ME NIGOU • Tuberculosis & Infection Biology Department, Institut de Pharmacologie et
de Biologie Structurale (IPBS), Centre National de la Recherche Scientifique (CNRS),
Toulouse, France; Universite ´ de Toulouse, Universite ´ Paul Sabatier (Toulouse III), Toulouse,
France
JAHN NITSCHKE • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
ANIL K. OJHA • Division of Genetics, Wadsworth Center, New York State Department of
Health, Albany, NY, USA; Department of Biomedical Sciences, University at Albany,
Albany, NY, USA
ANDREW J. OLIVE • Department of Microbiology and Molecular Genetics, Michigan State
University, East Lansing, MI, USA
TANYA PARISH • Center for Global Infectious Disease Research, Seattle Children’s Research
Institute, Seattle, WA, USA
MARI ´ A PEN ˜ A • United States Department of Health and Human Services, Health Resources
and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease
Program, Baton Rouge, LA, USA
ESTHER PE ´ REZ-HERRA ´ N • Gobal Health Phama Research Unit, Tres Cantos Medicines
Development Campus (TCMDC), GlaxoSmithKline, Madrid, Spain
KYLE A. PLANCK • Division of Infectious Diseases, Department of Medicine, Weill Cornell
Medicine, New York, NY, USA; Department of Pharmacology, Weill Cornell Medicine,
New York, NY, USA
KYU RHEE • Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine,
New York, NY, USA; Department of Microbiology and Immunology, Weill Cornell
Medicine, New York, NY, USA
MARCO A. RIOJAS • ATCC, BEI Resources, Manassas, VA, USA
JEREMY M. ROCK • Laboratory of Host-Pathogen Biology, The Rockefeller University, New
York, NY, USA
LILIANA RODRIGUES • Global Health and Tropical Medicine, GHTM, Instituto de Higiene
e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisbon, Portugal
JOAN M. RYAN • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
MAX SALFINGER • College of Public Health & Morsani College of Medicine, University of
South Florida, Tampa, FL, USA
SCARLET S. SHELL • Department of Biology & Biotechnology, Worcester Polytechnic Institute,
Worcester, MA, USA; Program in Bioinformatics & Computational Biology, Worcester
Polytechnic Institute, Worcester, MA, USA
xiv
Contributors